Abstract
The mechanism of the elevation of hepatic NAD level in the rats administered clofibrate and other peroxisome-proliferators were investigated. In the hepatocytes from the clofibrate-fed rats, NAD biosynthesis from Trp, but not from nicotinic acid, was specifically stimulated. The activities of peroxisomal marker enzymes, the peroxisome-proliferator activated receptors (PPAR)-dependent enzymes and key enzymes in the Trp-NAD pathway changed in parallel with the hepatic NAD increase; the activity of quinolinate phosphori-bosyltransferase (QPRT) was increased whereas that of α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD) was drastically reduced. The results strongly suggest that the hepatic NAD increase might be caused by transcription of genes coding the key enzymes of the Trp-NAD pathway via PPAR.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Auwerx, J., Schoonjans, K., Fruchart, J., and Staels, B., 1996, Regulation of triglyceride metabolism by PPARs: Fibrates and thiazolidiones have distinct effects, J. Atheroscler. Thromb. 3:81–89.
Hashimoto, T., 1982, Individual peroxisomal β-oxidation enzymes, Ann. N. Y. Acad. Sci. 386:5–12.
Loo, Y., Shin, M., Yamashita, Y., Ishigami, M., Sasaki, M., Sano, K., and Umezawa, C., 1995, Effect of feeding the clofibrate-containing diet on the hepatic NAD+ level in rats, J. Nutr. Sci. Vitaminol. 41:341–347.
Mannuerts, G.P. and Debeer, L.J., 1982, Mitochondrial and peroxisomal β-oxidation of fatty acids in rat liver, Ann. N. Y. Acad. Sci. 386:30–39.
Nasu, S., Yamaguchi, K., Sakakibara, S., Imai, H., and Ueda, I., 1981, The effect of pyrazines on the metabolism of tryptophan and nicotinamide adenine dinucleotide in the rat. Evidence of the formation of a potent inhibitor of aminocarboxy-muconate-semialdehyde decarboxylase from pyrazinamide, Biochim. Biophys. Acta 677:109–119.
Shibata, K., Kondo, T., Marugami, M., and Umezawa, C., 1996, Increased conversion ratio of tryptophan to niacin by the administration of clofibrate, a hypolipidemic drug, to rats, Biosci. Biotech. Biochem. 60:1455–1459.
Shin, M., Mori, Y., Kimura, A., Fujita, Y., Yoshida, K., Sano, K., and Umezawa, C., 1996, NAD+ biosynthesis and metabolic fluxes of tryptophan in hepatocytes isolated from rats fed a clofibrate-containing diet, Biochem. Pharmacol. 52:247–252.
Shin, M., Nakakita, S., Hashimoto, C., Sano, K., and Umezawa, C., 1997, NAD+ biosynthesis from tryptophan in the presence of nicotinic acid or vice versa by rat hepatocytes—Effect of clofibrate-feeding, Internat. J. Vit. Nutr. Res. 68:104–108.
Shin, M., Iwamoto, N., Yamashita, M., Sano, K., and Umezawa, C., 1998a, Pyridine nucleotide levels in liver of rats fed clofibrate—or pyrazinamide-containing diets, Biochem. Pharmacol. 55:367–371.
Shin, M., Asada, S., Mizumori, N., Sano, K., and Umezawa, C., 1998b, Effect of thioridazine or chlorpromazine on increased hepatic NAD+ level in rats fed clofibrate, a hypolipidaemic drug, J. Pharm. Pharmacol. 50:431–436.
Shindo, Y., Osumi, T., and Hashimoto, T., 1978, Effects of administration of di-(2-ethylhexyl) phthalate on rat liver mitochondria, Biochem. Pharmacol. 27:2683–2688.
Skorin, C., Necochea, C., Johow, V., Sato, U., Grau, A.M., Bremer, J., and Leighton, F., 1992, Peroxisomal fatty aid oxidation and inhibitors of the mitochondrial carnithine palmitoyltransferase I in isolated rat hepatocytes, Biochem. J. 281:561–567.
Skrede, S. and Halvorsen, O., 1979, Increased biosynthesis of CoA in the liver of rats treated with clofibrate, Eur. J. Biochem. 98:223–229.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shin, M., Sano, K., Umezawa, C. (1999). Effects of Peroxisome-Proliferators on the Trp-Nad Pathway. In: Huether, G., Kochen, W., Simat, T.J., Steinhart, H. (eds) Tryptophan, Serotonin, and Melatonin. Advances in Experimental Medicine and Biology, vol 467. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4709-9_43
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4709-9_43
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7133-5
Online ISBN: 978-1-4615-4709-9
eBook Packages: Springer Book Archive